Clinical trials research potential new treatments for people living with MS. Nearly 1 million people in the U.S. have been diagnosed with MS. Symptoms vary from person to person, but most commonly include fatigue and difficulty walking. Relapsing-remitting MS (RRMS) is the most common disease course – approximately 85% of people with MS are first diagnosed with this type.
Clinical trials test whether a new potential treatment is safe and effective for patients. There are many reasons people choose to join clinical trials, including access to treatment, receiving quality care, and helping research. The decision to join a clinical trial is always a choice, and you can leave a clinical trial at any time, for any reason.